CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1.
CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1.
复制标题
DOI:
10.4049/jimmunol.1701592
复制
发表时间:
2018-07-15
期刊:
影响因子:
--
通讯作者:
Benveniste EN
中科院分区:
文献类型:
--
作者:
Gibson SA;Yang W;Yan Z;Qin H;Benveniste EN
Growing evidence demonstrates that the highly conserved serine/threonine kinase CK2 promotes Th17 cell differentiation while suppressing the generation of Foxp3+ Tregs; however, the exact mechanism by which CK2 regulates the Th17/Treg axis remains unclear. CK2 can be comprised of 3 distinct subunits: 2 catalytic subunits, CK2α and CK2α′, and the regulatory subunit, CK2β. We generated mice that lack the major catalytic subunit of CK2, CK2α, specifically in mature T cells utilizing the distal Lck-Cre (CK2α−/−). Importantly, CK2α deficiency resulted in a significant decrease in the overall kinase activity of CK2. Further, CK2α deficiency resulted in a significant defect in Th17 cell polarization and a reciprocal increase in Tregs both in vitro and in vivo in the context of autoimmune neuroinflammation. The transcription factor FoxO1 directly inhibits Th17 cell differentiation and is essential for the generation of Tregs. CK2α−/− CD4+ T cells exhibit less phosphorylated FoxO1 and a corresponding increase in the transcription of FoxO1-regulated genes. Treatment of CK2α−/− CD4+ T cells with the FoxO1 inhibitor AS1842856 or shRNA knockdown of Foxo1 is sufficient to rescue Th17 cell polarization. Through utilization of a genetic approach to target CK2 kinase activity, the current study provides evidence of a major mechanism by which CK2 regulates the Th17/Treg axis through the inhibition of FoxO1.
登录
查看更多内容
DOI:
10.4049/jimmunol.1402554
发表时间:
2015-05-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Hawse WF;Sheehan RP;Miskov-Zivanov N;Menk AV;Kane LP;Faeder JR;Morel PA
通讯作者:
Morel PA
影响因子:
4.3
作者:
Lupp, Sarah;Gumhold, Catalina;Rother, Karen
通讯作者:
Rother, Karen
影响因子:
4
作者:
Huang, Haojie;Tindall, Donald J.
通讯作者:
Tindall, Donald J.
影响因子:
12.4
作者:
Di Maira, G;Salvi, M;Ruzzene, M
通讯作者:
Ruzzene, M
DOI:
10.3390/ph10010027
发表时间:
2017-03-05
期刊:
Pharmaceuticals (Basel, Switzerland)
影响因子:
--
作者:
Nuñez de Villavicencio-Diaz T;Rabalski AJ;Litchfield DW
通讯作者:
Litchfield DW